Shareholder Issues Sample Clauses

Shareholder Issues. (i) Within thirty (30) days after the Succession Event affecting the Terminating Doctor, the Terminating Doctor shall sell to the Corporation, and the Corporation shall purchase from the Terminating Doctor, the Shares held by the Terminating Doctor in the Corporation. The aggregate purchase price for the Shares shall be Dollars ($ ). (ii) As soon as reasonably practicable following the Succession Event affecting the Terminating Doctor and repurchase of the Terminating Doctor’s Shares, the Corporation shall sell one (1) newly issued share in the Corporation to a Qualified Medical Professional selected by the Board of Directors who’ is then employed by or on the Board of Directors of, or an independent contractor to, the Management Company or an affiliate thereof (a “Successor Shareholder”). The purchase price for such Share shall be Dollars ($ ). It shall be a condition to such sale that the Successor Shareholder (a) be appointed to the Board of Directors of the Corporation, and (b) agree in writing to become a party to this Agreement as a Doctor successor to the Terminating Doctor. (iii) Each Successor Shareholder shall be a Qualified Medical Professional, and each Successor Shareholder shall also be an employee or member of the Board of Directors of, or an independent contractor to, the Management Company or an affiliate thereof.
View SourceView Similar (2)
Shareholder Issues. (i) As soon as reasonably practicable following the death of the Decedent, the Decedent’s estate shall sell to the Corporation, and the Corporation shall purchase from the Decedent’s estate, the Shares held by the Decedent in the Corporation.. The aggregate purchase price for the Shares held by that Decedent in the Corporation shall be Dollars ($ ). (ii) As soon as reasonably practicable following the death of the Decedent and repurchase of the Decedent’s Shares, the Corporation shall sell one (1) newly issued share in the Corporation to a Qualified Medical Professional selected by the Board of Directors who is or upon issuance of shares will be a shareholder of the Corporation and is then employed by, contracting with or on the Board of Directors of the Management Company or an affiliate thereof (a “Successor Shareholder”). The purchase price for such Share shall be Dollars ($ ). It shall be a condition to such sale that the Successor Shareholder (a) be appointed to the Board of Directors of the Corporation, and (b) agree in writing to become a party to this Agreement as a Doctor successor to the Decedent. (iii) Each Successor Shareholder shall be a Qualified Medical Professional, and each Successor Shareholder shall also be an employee or member of the Board of Directors of, or independent contractor to, the Management Company or an affiliate thereof. Each Successor Shareholder shall be designated as being eligible to be a shareholder and director of the Corporation by the Management Company’s Board of Directors.
View SourceView Similar (2)
Shareholder Issues. In the event of the permanent disability or permanent incapacity of Dr. ▇▇▇▇▇ ▇▇ determined by a recognized medical authority, then the Shares shall be sold and transferred to the Medical Group in accordance with Article III of the Bylaws of the Medical Group. In such event, the Medical Group shall sell newly issued shares to a Successor Shareholder in the manner set forth in paragraph 3.1 herein.
View SourceView Similar (2)
Shareholder Issues. If Dr. ▇▇▇▇▇▇▇▇▇▇ ▇▇ the remaining sole shareholder of the Medical Group, then in the event of death of the last survivor, if legal counsel for the Medical Group determines that ownership of the Shares by the representative or successor-in-interest to the survivor is not permitted or legal under the Professional Corporation Act, then such Shares shall be sold and transferred to the Medical Group in accordance with Article III of the Bylaws of the Medical Group. In such event, the Medical Group shall, in order to have one (1) shareholder, do one of the following: (a) The Medical Group shall sell one hundred (100) newly issued shares to Thom▇▇ ▇. ▇▇▇▇▇▇▇, ▇.D., or his designee, who shall be designated the "Successor Shareholder" hereunder, and shall agree to purchase such shares; provided that such sale shall be consummated only if Dr. ▇▇▇▇▇▇▇ ▇▇ his designee is a Qualified Medical Professional on the Board of Directors of Raytel Medical Corporation; or
View SourceView Similar (2)
Shareholder Issues. In the event of: (a) voluntary resignation by Dr. ▇▇▇▇▇ ▇▇ an officer and director of the Medical Group;
View SourceView Similar (2)
Shareholder Issues. As soon as reasonably practicable following written notice from Bank of the occurrence of a Succession Event and upon receipt of Bank's written demand therefor, ▇▇▇▇▇▇▇▇, or his estate, as the case may be, shall sell the Shares to such person(s) as Bank shall, in its sole discretion, direct (the "NEW SHAREHOLDER(S)"). The total purchase price for the Shares shall be $1,000.
View Source
Shareholder Issues. As soon as reasonably practicable following written notice from Bank of the occurrence of a Succession Event and upon receipt of Bank's written demand therefor, the PC Shareholders, or their estate, as the case may be, shall sell the Shares to such person(s) as Bank shall, in its sole discretion, direct (the "NEW SHAREHOLDER(S)"). The total purchase price for the Shares for each Professional Corporation shall be $1,000.
View Source
Shareholder Issues. As soon as reasonably practicable following written notice from Lender of the occurrence of a Succession Event and upon receipt of Lender's written demand therefor, the PC Shareholders, or their estate, as the case may be, shall sell the Shares to such person(s) as Lender shall, in its sole discretion, direct (the "New Shareholder(s)"). The total purchase price for the Shares for each Professional Corporation shall be $1,000.
View Source

Related to Shareholder Issues

  • Warrant Holder Not Shareholder This Warrant does not confer upon the holder hereof any right to vote or to consent or to receive notice as a shareholder of the Company, as such, in respect of any matters whatsoever, or any other rights or liabilities as a shareholder, prior to the exercise hereof as hereinbefore provided.

  • FINRA Member Shareholders There are no affiliations with any FINRA member firm among the Company’s officers, directors or, to the knowledge of the Company, any five percent (5%) or greater stockholder of the Company, except as set forth in the Registration Statement, the Base Prospectus, any Prospectus Supplement or the Prospectus.

  • Warrantholder not a Shareholder Except as may be specifically provided herein, nothing in this Indenture or in the holding of a Warrant Certificate, entitlement to a Warrant or otherwise, shall, in itself, confer or be construed as conferring upon a Warrantholder any right or interest whatsoever as a Shareholder, including, but not limited to, the right to vote at, to receive notice of, or to attend, meetings of Shareholders or any other proceedings of the Corporation, or the right to Dividends and other allocations.

  • Stockholder No holder, as such, of any Right Certificate shall be entitled to vote, receive dividends or be deemed for any purpose the holder of the Preferred Shares or any other securities of the Company which may at any time be issuable on the exercise of the Rights represented thereby, nor shall anything contained herein or in any Right Certificate be con- strued to confer upon the holder of any Right Certificate, as such, any of the rights of a stockholder of the Company or any right to vote for the election of directors or upon any matter submitted to stockholders at any meeting thereof, or to give or withhold consent to any corporate action, or to receive notice of meetings or other actions affecting stock- holders (except as provided in Section 25 hereof), or to re- ceive dividends or subscription rights, or otherwise, until the Right or Rights evidenced by such Right Certificate shall have been exercised in accordance with the provisions hereof.

  • Shareholder Loans ▇▇▇▇▇▇ ▇▇▇▇▇▇ 19.22 (Shareholder Loans) and make any other necessary consequential amendments.